Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

Eli Lilly total long term liabilities for the quarter ending June 30, 2024 were $31.118B, a 25.73% increase year-over-year.

  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.
  • Eli Lilly total long term liabilities for 2021 were $24.599B, a 13.16% decline from 2020.

Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.
  • Eli Lilly total long term liabilities for 2021 were $24.599B, a 13.16% decline from 2020.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M